{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-25-009007","form_type":"8-K","ticker":null,"cik":"0001289047","company_name":"AI Technology Group Inc.","filed_at":"2025-12-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.036181+00:00","generated_at":"2026-05-16T12:53:37.655854+00:00","sec_items":["1.01","2.01","3.02","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"AI Technology Group acquires AVM Biotechnology via share exchange; issues 100 common shares","bullets":["Acquired 100% of AVM Biotechnology Inc. for 100 common shares of AI Technology Group.","AVM becomes wholly-owned subsidiary; transaction intended as tax-free reorganization under Section 368.","AVM has $1.125M convertible debentures outstanding, convertible into 584,800 common shares of the acquirer.","Shares issued as restricted securities under Rule 144, exempt from registration under Section 4(a)(2)."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-25-009007","json":"https://secwatch.observer/filing/0001477932-25-009007.json","markdown":"https://secwatch.observer/filing/0001477932-25-009007.md","text":"https://secwatch.observer/filing/0001477932-25-009007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1289047/000147793225009007/0001477932-25-009007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1289047/000147793225009007/aipg_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:53:37.655854+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f0667b3bd300af432e84c6ca8962daca10b40835","claim":"AI Technology Group Inc. completed an acquisition involving AVM Biotechnology Inc. for 100 common shares of the Corporation (closed 2025-12-15).","evidence_excerpt":"and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”), the sole shareholder of AVM. Under the terms of the agreement, the Corporation agreed to acquire 100% of the issued and outstanding shares of AVM in exchange for 100 common shares of the Corporation . As a result, AVM became a wholly-owned subsidiary of the Corporation. The","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1289047/000147793225009007/0001477932-25-009007-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001493152-26-021306","ticker":"OTLC","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2026-05-05T23:59:59+00:00","headline":"Oncotelic completes merger transferring patent portfolio to Lunai for $20M Series B Preferred stock","event_type":"m_and_a","sec_items":["1.01","2.01","3.02","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 3.02, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-021306","json":"https://secwatch.observer/filing/0001493152-26-021306.json","markdown":"https://secwatch.observer/filing/0001493152-26-021306.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315226021306/0001493152-26-021306-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315226021306/form8-k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”), the sole shareholder of AVM. Under the terms of the agreement, the Corporation agreed to acquire 100% of the issued and outstanding shares of AVM in exchange for 100 common shares of the Corporation . As a result, AVM became a wholly-owned subsidiary of the Corporation. The","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1289047/000147793225009007/0001477932-25-009007-index.htm","comparable_excerpt":"greement and Plan of Merger (the “Merger Agreement”) with Lunai Bioworks, Inc., a Delaware corporation (“Lunai”),\nLunai Bioworks IP, Inc., a Delaware corporation and a wholly owned subsidiary of Lunai (“Merger Sub”), Neurobridge IP Holdings","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/908259/000149315226021306/0001493152-26-021306-index.htm"}},{"accession":"0001104659-26-050956","ticker":"RMIX","company_name":"Suncrete, Inc.","filed_at":"2026-04-29T23:59:59+00:00","headline":"Suncrete completes acquisition of Hope Concrete (10 plants, 88 trucks) for $39.4M + equity","event_type":"m_and_a","sec_items":["1.01","2.01","3.02","7.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 3.02, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-050956","json":"https://secwatch.observer/filing/0001104659-26-050956.json","markdown":"https://secwatch.observer/filing/0001104659-26-050956.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2094433/000110465926050956/0001104659-26-050956-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2094433/000110465926050956/tm2613031d1_8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”), the sole shareholder of AVM. Under the terms of the agreement, the Corporation agreed to acquire 100% of the issued and outstanding shares of AVM in exchange for 100 common shares of the Corporation . As a result, AVM became a wholly-owned subsidiary of the Corporation. The","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1289047/000147793225009007/0001477932-25-009007-index.htm","comparable_excerpt":"in its capacity as representative of the Sellers. After giving effect to the\ntransactions contemplated by the Purchase Agreement, the aggregate consideration consisted of (i) 220,007 shares (the “Mikytuck\nRollover Securities”) of Class A Common Stock, par value $0.0001 per share, of the Company (“Class A Common Stock”)\nissued to Mr. Mikytuck, (ii) 69,511","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2094433/000110465926050956/0001104659-26-050956-index.htm"}},{"accession":"0001683168-26-003159","ticker":"IVHI","company_name":"Invech Holdings, Inc.","filed_at":"2026-04-23T23:59:59+00:00","headline":"Invech buys sportypick.com sports betting platform for 5M restricted shares of IVHI stock","event_type":"m_and_a","sec_items":["1.01","2.01","3.02","8.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 3.02, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-003159","json":"https://secwatch.observer/filing/0001683168-26-003159.json","markdown":"https://secwatch.observer/filing/0001683168-26-003159.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1009919/000168316826003159/0001683168-26-003159-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1009919/000168316826003159/invech_8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”), the sole shareholder of AVM. Under the terms of the agreement, the Corporation agreed to acquire 100% of the issued and outstanding shares of AVM in exchange for 100 common shares of the Corporation . As a result, AVM became a wholly-owned subsidiary of the Corporation. The","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1289047/000147793225009007/0001477932-25-009007-index.htm","comparable_excerpt":"has agreed to sell and the Company has agreed to purchase the website and total code of the sports betting platform\nwww.sportypick.com owned by Day (the “Assets”) in exchange for 5,000,000 restricted shares of common stock of the Company\n(the “Shares”). The foregoing information is a summary of the\nAPA involved in the transaction described above, is not complete,","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1009919/000168316826003159/0001683168-26-003159-index.htm"}},{"accession":"0001213900-26-042811","ticker":"PHGE","company_name":"BiomX Inc.","filed_at":"2026-04-13T23:59:59+00:00","headline":"BiomX accelerates option exercise, acquires 60% stake in DFSL for $750k cash, $3M note","event_type":"m_and_a","sec_items":["1.01","2.01","3.02","7.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 3.02, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-042811","json":"https://secwatch.observer/filing/0001213900-26-042811.json","markdown":"https://secwatch.observer/filing/0001213900-26-042811.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026042811/0001213900-26-042811-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026042811/ea0285293-8k_biomx.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”), the sole shareholder of AVM. Under the terms of the agreement, the Corporation agreed to acquire 100% of the issued and outstanding shares of AVM in exchange for 100 common shares of the Corporation . As a result, AVM became a wholly-owned subsidiary of the Corporation. The","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1289047/000147793225009007/0001477932-25-009007-index.htm","comparable_excerpt":"delivery. In consideration for the Purchased Shares, the\nCompany agreed to the following consideration to Mandragola: (i) a cash payment of Seven Hundred Fifty Thousand Dollars ($750,000),\nof which Four Hundred Fifty Thousand ($450,000) was advanced by the Company; (ii) the issuance of an unsecured convertible promissory note in the principal\namount of Three","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026042811/0001213900-26-042811-index.htm"}},{"accession":"0001731122-26-000555","ticker":"VWAV","company_name":"VisionWave Holdings, Inc.","filed_at":"2026-04-13T23:59:59+00:00","headline":"VisionWave acquires xClibre AI video IP for 7M shares + $6M note; $60M valuation","event_type":"m_and_a","sec_items":["1.01","2.01","3.02","9.01","8.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 3.02, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000555","json":"https://secwatch.observer/filing/0001731122-26-000555.json","markdown":"https://secwatch.observer/filing/0001731122-26-000555.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2038439/000173112226000555/0001731122-26-000555-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2038439/000173112226000555/e7553_8-k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”), the sole shareholder of AVM. Under the terms of the agreement, the Corporation agreed to acquire 100% of the issued and outstanding shares of AVM in exchange for 100 common shares of the Corporation . As a result, AVM became a wholly-owned subsidiary of the Corporation. The","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1289047/000147793225009007/0001477932-25-009007-index.htm","comparable_excerpt":"Company”) entered into an Asset Purchase Agreement (the “Agreement”) with Dream America Marketing Services, Ltda.,\na Costa Rican company (the “Seller”). Pursuant to the Agreement, the Company agreed to acquire","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2038439/000173112226000555/0001731122-26-000555-index.htm"}},{"accession":"0001213900-26-042200","ticker":"PHGE","company_name":"BiomX Inc.","filed_at":"2026-04-10T23:59:59+00:00","headline":"BiomX acquires ZorroNet, enters AI defense with $1.25M note and stock","event_type":"m_and_a","sec_items":["1.01","2.01","3.02","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 3.02, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-042200","json":"https://secwatch.observer/filing/0001213900-26-042200.json","markdown":"https://secwatch.observer/filing/0001213900-26-042200.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026042200/0001213900-26-042200-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026042200/ea0285346-8k_biomx.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”), the sole shareholder of AVM. Under the terms of the agreement, the Corporation agreed to acquire 100% of the issued and outstanding shares of AVM in exchange for 100 common shares of the Corporation . As a result, AVM became a wholly-owned subsidiary of the Corporation. The","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1289047/000147793225009007/0001477932-25-009007-index.htm","comparable_excerpt":"active engagements with Elbit Systems Ltd (TASE/Nasdaq: ESLT) and other top\nIsrael’s preeminent defense prime contractors. As consideration, the Company issued to Water\nIO: (i) 1,300,000 shares of common stock ; and (ii) a non-convertible promissory note in the amount of $1,250,000 , bearing\ninterest at the short-term applicable federal rate, payable July 7, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026042200/0001213900-26-042200-index.htm"}},{"accession":"0001213900-26-041119","ticker":"HCTI","company_name":"Healthcare Triangle, Inc.","filed_at":"2026-04-07T23:59:59+00:00","headline":"Acquired Teyamé 360 reports FY2025 revenue $17.2M, net profit $1.1M","event_type":"m_and_a","sec_items":["9.01","1.01","2.01","3.02","7.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 3.02, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-041119","json":"https://secwatch.observer/filing/0001213900-26-041119.json","markdown":"https://secwatch.observer/filing/0001213900-26-041119.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1839285/000121390026041119/0001213900-26-041119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1839285/000121390026041119/ea0285446-8ka1_healthcare.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”), the sole shareholder of AVM. Under the terms of the agreement, the Corporation agreed to acquire 100% of the issued and outstanding shares of AVM in exchange for 100 common shares of the Corporation . As a result, AVM became a wholly-owned subsidiary of the Corporation. The","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1289047/000147793225009007/0001477932-25-009007-index.htm","comparable_excerpt":"relating to the acquisition by Teyame AI Holdings Inc., the Company’s wholly owned subsidiary, of all of the outstanding equity interests of Teyamé 360 S.L. and Datono Mediación S.L. pursuant to that certain Share Purchase Agreement, dated January 22, 2026","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1839285/000121390026041119/0001213900-26-041119-index.htm"}},{"accession":"0001213900-26-039507","ticker":null,"company_name":"KiNRG, Inc.","filed_at":"2026-04-02T23:59:59+00:00","headline":"KiNRG acquires Trinity Group Construction for $8.2M in cash, stock, and note","event_type":"m_and_a","sec_items":["1.01","2.01","3.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 3.02, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-039507","json":"https://secwatch.observer/filing/0001213900-26-039507.json","markdown":"https://secwatch.observer/filing/0001213900-26-039507.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/95572/000121390026039507/0001213900-26-039507-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/95572/000121390026039507/ea0284904-8k_kinrg.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”), the sole shareholder of AVM. Under the terms of the agreement, the Corporation agreed to acquire 100% of the issued and outstanding shares of AVM in exchange for 100 common shares of the Corporation . As a result, AVM became a wholly-owned subsidiary of the Corporation. The","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1289047/000147793225009007/0001477932-25-009007-index.htm","comparable_excerpt":"the Company\nagreed to acquire 100% of the issued and outstanding capital stock of Trinity (the “Acquisition”). Purchase Price The aggregate purchase price for the Acquisition is $8,200,000, consisting\nof: (i) $1,000,000 in cash, (ii) 4,200,000 shares of KiNRG common stock, par value $0.0001 per share, and (iii) a promissory note in the\nprincipal amount of $3,000,000","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/95572/000121390026039507/0001213900-26-039507-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}